Ryan Fleishmann
YOU?
Author Swipe
View article: Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis
Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis Open
Summary Over 50% of patients with systemic LCH are not cured with front‐line therapies, and data to guide salvage options are limited. We describe 58 patients with LCH who were treated with clofarabine. Clofarabine monotherapy was active a…